1. Home
  2. ELSE vs INAB Comparison

ELSE vs INAB Comparison

Compare ELSE & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

N/A

Current Price

$4.37

Market Cap

15.4M

Sector

Industrials

ML Signal

N/A

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.32

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
INAB
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
14.2M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ELSE
INAB
Price
$4.37
$1.32
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
4.2K
71.9K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$10,142,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.78
N/A
Revenue Growth
8.20
N/A
52 Week Low
$3.65
$0.12
52 Week High
$5.29
$4.20

Technical Indicators

Market Signals
Indicator
ELSE
INAB
Relative Strength Index (RSI) 49.21 39.31
Support Level $4.08 $1.35
Resistance Level $4.45 $2.14
Average True Range (ATR) 0.09 0.11
MACD -0.00 -0.01
Stochastic Oscillator 45.45 22.22

Price Performance

Historical Comparison
ELSE
INAB

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: